IGF-1 deficiency impairs cerebral myogenic autoregulation in hypertensive mice

Journal of Cerebral Blood Flow and Metabolism

Volumn 34, Issue 12, 2014, Pages 1887-1897

  Toth, Peter ^a,b   Tucsek, Zsuzsanna ^a   Tarantini, Stefano ^a   Sosnowska, Danuta ^a   Gautam, Tripti ^a   Mitschelen, Matthew ^a   Koller, Akos ^b,c   Sonntag, William E ^a,d   Csiszar, Anna ^a,b,d   Ungvari, Zoltan ^a,b,d  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF PÉCS   (Hungary)

^c NEW YORK MEDICAL COLLEGE   (United States)

^d UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

blood brain barrier; cerebral blood flow; dementia; neuroinflammation; TRPC; VCI

Indexed keywords

ADIPONECTIN; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; SOMATOMEDIN C; TRANSIENT RECEPTOR POTENTIAL CHANNEL C; ANGIOTENSIN II; BIOLOGICAL MARKER; VASOCONSTRICTOR AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOREGULATION; BLOOD BRAIN BARRIER; BLOOD PRESSURE MEASUREMENT; BRAIN BLOOD FLOW; BRAIN MICROCIRCULATION; CEREBROVASCULAR AUTOREGULATION; COGNITION; CONTROLLED STUDY; EXPERIMENTAL HYPERTENSION; GENE EXPRESSION; HIPPOCAMPUS; MALE; MIDDLE CEREBRAL ARTERY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; SOMATOMEDIN C DEFICIENCY; SYSTOLIC BLOOD PRESSURE; UPREGULATION; 129 MOUSE; AGING; ANIMAL; BLOOD; BRAIN CIRCULATION; C57BL MOUSE; DEFICIENCY; DEMENTIA; DISEASE MODEL; DRUG EFFECTS; ENCEPHALITIS; GENETICS; HOMEOSTASIS; HYPERTENSION; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; MICROGLIA; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGING; ANGIOTENSIN II; ANIMALS; BIOMARKERS; BLOOD-BRAIN BARRIER; CEREBROVASCULAR CIRCULATION; DEMENTIA; DISEASE MODELS, ANIMAL; ENCEPHALITIS; HIPPOCAMPUS; HOMEOSTASIS; HYPERTENSION; INSULIN-LIKE GROWTH FACTOR I; MALE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROGLIA; MIDDLE CEREBRAL ARTERY; TRPC CATION CHANNELS; VASOCONSTRICTOR AGENTS;

EID: 84927178628     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2014.156     Document Type: Article

References (41)

1. Kontos HA, Wei EP, Navari RM, Levasseur JE, Rosenblum WI, Patterson JL, Jr. Responses of cerebral arteries and arterioles to acute hypotension and hypertension. Am J Physiol 1978; 234: H371-H383.
2. Harper SL, Bohlen HG. Microvascular adaptation in the cerebral cortex of adult spontaneously hypertensive rats. Hypertension 1984; 6: 408-419.
3. Kontos HA, Wei EP, Raper AJ, Rosenblum WI, Navari RM, Patterson JL, Jr. Role of tissue hypoxia in local regulation of cerebral microcirculation. Am J Physiol 1978; 234: H582-H591.
4. Paulson OB, Strandgaard S, Edvinsson L. Cerebral autoregulation. Cerebrovasc Brain Metab Rev. 1990; 2: 161-192.
5. Strandgaard S, Jones JV, MacKenzie ET, Harper AM. Upper limit of cerebral blood flow autoregulation in experimental renovascular hypertension in the baboon. Circ Res 1975; 37: 164-167.
6. Osol G, Halpern W. Myogenic properties of cerebral blood vessels from normotensive and hypertensive rats. Am J Physiol 1985; 249: H914-H921.
7. Smeda JS. Cerebral vascular changes associated with hemorrhagic stroke in hypertension. Can J Physiol Pharmacol 1992; 70: 552-564.
8. Kang LS, Kim S, Dominguez JM, 2nd, Sindler AL, Dick GM, Muller-Delp JM. Aging and muscle fiber type alter K+ channel contributions to the myogenic response in skeletal muscle arterioles. J Appl Physiol 2009; 107: 389-398.
9. Lott ME, Herr MD, Sinoway LI. Effects of age on brachial artery myogenic responses in humans. Am J Physiol Regul Integr Comp Physiol 2004; 287: R586-R591.
10. Toth P, Tucsek Z, Sosnowska D, Gautam T, Mitschelen M, Tarantini S et al. Agerelated autoregulatory dysfunction and cerebromicrovascular injury in mice with angiotensin II-induced hypertension. J Cereb Blood Flow Metab. 2013; 33: 1732-1742.
11. Toth P, Csiszar A, Tucsek Z, Sosnowska D, Gautam T, Koller A et al. Role of 20-HETE, TRP channels & BKCa in dysregulation of pressure-induced Ca2+ signaling and myogenic constriction of cerebral arteries in aged hypertensive mice. Am J Physiol Heart Circ Physiol 2013; 305: H1698-H1708.
12. Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42: 2672-2713.
13. Aronow WS, Fleg JL, Pepine CJ, Artinian NT, Bakris G, Brown AS et al. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: A report of the american college of cardiology foundation task force on clinical expert consensus documents. Circulation 2011; 123: 2434-2506.
14. Sonntag WE, Deak F, Ashpole N, Toth P, Csiszar A, Freeman W et al. Insulin-like growth factor-1 in CNS and cerebrovascular aging. Front Aging Neurosci 2013; 5: 27.
15. Ungvari Z, Csiszar A. The emerging role of IGF-1 deficiency in cardiovascular aging: recent advances. J Gerontol A Biol Sci Med Sci 2012; 67: 599-610.
16. Angelini A, Bendini C, Neviani F, Bergamini L, Manni B, Trenti T et al. Insulin-like growth factor-1 (IGF-1): Relation with cognitive functioning and neuroimaging marker of brain damage in a sample of hypertensive elderly subjects. Arch Gerontol Geriatr 2009; 49(Suppl 1):5-12.
17. Johnsen SP, Hundborg HH, Sorensen HT, Orskov H, Tjonneland A, Overvad K et al. Insulin-like growth factor (IGF) I, -II, and IGF binding protein-3 and risk of ischemic stroke. J Clin Endocrinol Metab 2005; 90: 5937-5941.
18. Laron Z, Klinger B, Silbergeld A. Patients with Laron syndrome have osteopenia/ osteoporosis. J Bone Miner Res 1999; 14: 156-157.
19. Sonntag WE, Carter CS, Ikeno Y, Ekenstedt K, Carlson CS, Loeser RF et al. Adultonset growth hormone and insulin-like growth factor 1 deficiency reduces neoplastic disease, modifies age-related pathology, and increases life span. Endocrinology 2005; 146: 2920-2932.
20. Kobayashi T, Kaneda A, Kamata K. Possible involvement of IGF-1 receptor and IGF-binding protein in insulin-induced enhancement of noradrenaline response in diabetic rat aorta. Br J Pharmacol 2003; 140: 285-294.
21. Lin JJ, Tonshoff B, Bouriquet N, Casellas D, Kaskel FJ, Moore LC. Insulin-like growth factor-1 restores microvascular autoregulation in experimental chronic renal failure. Kidney Int Suppl 1998; 67: S195-S198.
22. Bailey-Downs LC, Mitschelen M, Sosnowska D, Toth P, Pinto JT, Ballabh P et al. Liver-specific knockdown of IGF-1 decreases vascular oxidative stress resistance by impairing the Nrf2-dependent antioxidant response: A novel model of vascular aging. J Gerontol Biol Med Sci 2012; 67: 313-329.
23. Liu JL, Grinberg A, Westphal H, Sauer B, Accili D, Karas M et al. Insulin-like growth factor-1 affects perinatal lethality and postnatal development in a gene dosage-dependent manner: Manipulation using the cre/loxp system in transgenic mice. Mol Endocrinol 1998; 12: 1452-1462.
24. Ayata C, Dunn AK, Gursoy OY, Huang Z, Boas DA, Moskowitz MA. Laser speckle flowmetry for the study of cerebrovascular physiology in normal and ischemic mouse cortex. J Cereb Blood Flow Metab 2004; 24: 744-755.
25. Bell RD, Winkler EA, Singh I, Sagare AP, Deane R, Wu Z et al. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 2012; 485: 512-516.
26. Tivesten A, Bollano E, Andersson I, Fitzgerald S, Caidahl K, Sjogren K et al. Liverderived insulin-like growth factor-1 is involved in the regulation of blood pressure in mice. Endocrinology 2002; 143: 4235-4242.
27. Koller A, Toth P. Contribution of flow-dependent vasomotor mechanisms to the autoregulation of cerebral blood flow. J Vasc Res 2012; 49: 375-389.
28. Toth P, Rozsa B, Springo Z, Doczi T, Koller A. Isolated human and rat cerebral arteries constrict to increases in flow: Role of 20-HETE and TP receptors. J Cereb Blood Flow Metab 2011; 31: 2096-2105.
29. Zlokovic BV. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008; 57: 178-201.
30. Faraci FM, Heistad DD. Regulation of large cerebral arteries and cerebral microvascular pressure. Circ Res 1990; 66: 8-17.
31. New DI, Chesser AM, Thuraisingham RC, Yaqoob MM. Cerebral artery responses to pressure and flow in uremic hypertensive and spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 2003; 284: H1212-H1216.
32. Welsh DG, Morielli AD, Nelson MT, Brayden JE. Transient receptor potential channels regulate myogenic tone of resistance arteries. Circ Res 2002; 90: 248-250.
33. Kanzaki M, Zhang YQ, Mashima H, Li L, Shibata H, Kojima I. Translocation of a calcium-permeable cation channel induced by insulin-like growth factor-1. Nat Cell Biol 1999; 1: 165-170.
34. Gebremedhin D, Lange AR, Lowry TF, Taheri MR, Birks EK, Hudetz AG et al. Production of 20-HETE and its role in autoregulation of cerebral blood flow. Circ Res 2000; 87: 60-65.
35. Brickman AM, Reitz C, Luchsinger JA, Manly JJ, Schupf N, Muraskin J et al. Longterm blood pressure fluctuation and cerebrovascular disease in an elderly cohort. Arch Neurol 2010; 67: 564-569.
36. Reitz C, Tang MX, Manly J, Mayeux R, Luchsinger JA. Hypertension and the risk of mild cognitive impairment. Arch Neurol 2007; 64: 1734-1740.
37. Kuller LH, Lopez OL, Jagust WJ, Becker JT, DeKosky ST, Lyketsos C et al. Determinants of vascular dementia in the cardiovascular health cognition study. Neurology 2005; 64: 1548-1552.
38. Bellar D, Glickman EL, Juvancic-Heltzel J, Gunstad J. Serum insulin like growth factor-1 is associated with working memory, executive function and selective attention in a sample of healthy, fit older adults. Neuroscience 2011; 178: 133-137.
39. Goldbourt U, Tanne D. Body height is associated with decreased long-term stroke but not coronary heart disease mortality? Stroke 2002; 33: 743-748.
40. Parker DR, Lapane KL, Lasater TM, Carleton RA. Short stature and cardiovascular disease among men and women from two southeastern new england communities. Int J Epidemiol 1998; 27: 970-975.
41. Poels MM, Ikram MA, van der Lugt A, Hofman A, Krestin GP, Breteler MM et al. Incidence of cerebral microbleeds in the general population: The Rotterdam scan study. Stroke 2011; 42: 656-661.